Literature DB >> 10198789

Genetic vaccines.

J R Haynes1.   

Abstract

In a few short years, genetic vaccine technology has moved rapidly from a novel concept to an important strategy for the development of human and veterinary vaccines, for numerous indications. This article discusses current areas in which further refinements in technology will influence a variety of infectious disease treatments, including intramuscular and intradermal inoculation, gene gun inoculation, the mechanism of antigen presentation, and the use of genetic adjuvants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198789     DOI: 10.1016/s0891-5520(05)70040-4

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  2 in total

1.  Current and Future Use of Vaccines for Viral and Bacterial Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

2.  Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

Authors:  Joshua Arrington; Ralph P Braun; Lichun Dong; Deborah H Fuller; Michael D Macklin; Scott W Umlauf; Sarah J Wagner; Mary S Wu; Lendon G Payne; Joel R Haynes
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.